RT Journal Article
SR Electronic
T1 Characterizing cell type specific transcriptional differences between the living and postmortem human brain
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.05.01.24306590
DO 10.1101/2024.05.01.24306590
A1 Vornholt, Eric
A1 Liharska, Lora E.
A1 Cheng, Esther
A1 Hashemi, Alice
A1 Park, You Jeong
A1 Ziafat, Kimia
A1 Wilkins, Lillian
A1 Silk, Hannah
A1 Linares, Lisa M.
A1 Thompson, Ryan C.
A1 Sullivan, Brendan
A1 Moya, Emily
A1 Nadkarni, Girish N.
A1 Sebra, Robert
A1 Schadt, Eric E.
A1 Kopell, Brian H.
A1 Charney, Alexander W.
A1 Beckmann, Noam D.
YR 2024
UL http://medrxiv.org/content/early/2024/05/01/2024.05.01.24306590.abstract
AB Single-nucleus RNA sequencing (snRNA-seq) is often used to define gene expression patterns characteristic of brain cell types as well as to identify cell type specific gene expression signatures of neurological and mental illnesses in postmortem human brains. As methods to obtain brain tissue from living individuals emerge, it is essential to characterize gene expression differences associated with tissue originating from either living or postmortem subjects using snRNA-seq, and to assess whether and how such differences may impact snRNA-seq studies of brain tissue. To address this, human prefrontal cortex single nuclei gene expression was generated and compared between 31 samples from living individuals and 21 postmortem samples. The same cell types were consistently identified in living and postmortem nuclei, though for each cell type, a large proportion of genes were differentially expressed between samples from postmortem and living individuals. Notably, estimation of cell type proportions by cell type deconvolution of pseudo-bulk data was found to be more accurate in samples from living individuals. To allow for future integration of living and postmortem brain gene expression, a model was developed that quantifies from gene expression data the probability a human brain tissue sample was obtained postmortem. These probabilities are established as a means to statistically account for the gene expression differences between samples from living and postmortem individuals. Together, the results presented here provide a deep characterization of both differences between snRNA-seq derived from samples from living and postmortem individuals, as well as qualify and account for their effect on common analyses performed on this type of data.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNational Institute of Aging (R01AG069976). The Michael J. Fox Foundation (Grant 18232), National Institute of Mental Health (R01MH109897)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:STUDY-13-00415 of the Human Research Protection Program at the Icahn School of Medicine at Mount Sinai.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes